Arkema Earnings Call Flags Resilience Amid FX Drag

Arkema S.A. ((ARKAY)) has held its Q1 earnings call. Read on for the main highlights of the call.

Arkema’s latest earnings call struck a cautiously resilient tone, as management highlighted stable volumes, growing Specialty Materials and sequential EBITDA improvement despite a tough macro backdrop and geopolitical uncertainty. Still, investors had to digest an 8.4% revenue decline, year‑on‑year EBITDA pressure from currencies and soft demand in Europe and the U.S.

Stable Volumes and Specialty Materials Momentum

Group volumes were broadly stable in Q1 2026, suggesting that the bottom of the cycle may be holding despite weak macro sentiment. Specialty Materials volumes rose 1.5% with all segments contributing and a notable pickup in March, signaling improving traction in higher‑margin activities.

High-Growth End Markets Drive Double-Digit Volume Gains

Arkema’s most attractive niches continued to shine, with volumes in batteries, sports, 3D printing and healthcare up 15%. Battery applications were a standout, driven by strong energy‑storage demand and underpinning growth in the High Performance Polymers franchise.

Sequential EBITDA Recovery Outpaces Expectations

Q1 EBITDA came in at €283 million, up 14% versus Q4 2025 and slightly ahead of internal expectations. Management credited a better March performance for the rebound, cushioning the impact of a still‑challenging environment and underpinning confidence in near‑term improvement.

PIAM and Coating Solutions Deliver Margin Outperformance

The PIAM business posted more than 30% EBITDA growth in local currency and reached a robust 35% margin, underlining the strength of its portfolio. Coating Solutions improved its EBITDA margin by 100 basis points and grew volumes 3%, signaling early recovery in this cyclical segment.

Disciplined CapEx and Tight Cash Management

Capital allocation remained conservative, with Q1 CapEx at €75 million and on track for the €600 million full‑year plan. The working capital ratio improved to 16.3% year‑on‑year, helping deliver better recurring cash flow than last year despite seasonality.

Advancing Growth Projects and Capacity Expansions

Arkema is pushing ahead with strategic capacity builds, including a U.S. PVDF expansion adding about 15% capacity starting mid‑year. The group also announced a 20% PVDF expansion in China slated for 2028, while the Rilsan Clear unit in Singapore has started and should support HPP earnings from Q2.

Maintaining 2026 EBITDA Target and Cost Discipline

Management reiterated its ambition of slight EBITDA growth at constant FX for 2026 and emphasized ongoing cost‑cutting efforts. Actions to manage fixed‑cost inflation and protect margins are central to offsetting demand softness and currency headwinds.

Revenue Contraction Reflects FX and Pricing Pressure

Q1 revenues fell to €2.2 billion, down 8.4% year‑on‑year, highlighting the top‑line challenge facing the group. A negative currency effect of 5.1% and a 3% price decline in a weaker pricing environment drove most of the revenue contraction.

EBITDA Down Year-on-Year Amid Currency Drag

Despite the quarter‑on‑quarter rebound, EBITDA remained below the prior‑year level, illustrating the earnings pressure from the cycle. Management pointed to about €20 million of negative FX impact and the lack of a clear demand rebound in Europe and the U.S. as key contributors.

Europe and U.S. Demand Remain Subdued

Regional conditions stayed difficult in January and February, particularly in Europe and the U.S., weighing on Advanced Materials and Primary Materials. Packaging‑related activities also remained soft, limiting the scope for a broader volume recovery early in the year.

Inflationary Input Costs and Supply-Chain Risks

The conflict in the Middle East has pushed up certain raw materials, energy and logistics costs, with sulfur and other feedstocks singled out. Arkema faces time lags in passing these higher costs through to customers, adding volatility to margins in the near term.

Advanced Materials Hit by Slow Start and Mix Effects

Advanced Materials had a muted opening to 2026, reflecting both end‑market weakness and an unfavorable product and geographic mix. Growth skewed toward Asia is mechanically dilutive to unit margins, even as it supports overall volume resilience.

Negative Recurring Cash Flow and Nonrecurring Charges

Recurring cash flow was minus €95 million in Q1, mainly due to seasonal working capital needs typical for the first quarter. Nonrecurring items totaled €45 million, including €34 million of PPA depreciation and €11 million of one‑off restructuring and reorganization charges.

Higher Leverage and Rising Financial Expenses

Net debt including hybrid bonds stood at €3.3 billion at end‑March, equating to 2.8 times last‑twelve‑month EBITDA. Financial expenses increased, partly reflecting the cost of carry on green bonds issued at the end of 2024, adding a further drag to the bottom line.

Guidance and Outlook: Modest Growth with Better Q2

Arkema confirmed its full‑year 2026 goal of achieving slight EBITDA growth at constant FX and expects Q2 to be sequentially stronger, helped by High Performance Polymers and better acrylic spreads. The company is leaning on capacity ramp‑ups, disciplined CapEx and active cost measures to navigate FX, input‑cost and regional demand headwinds.

Looking ahead, Arkema is balancing near‑term macro softness with structural growth in Specialty Materials and high‑growth niches. For investors, the story remains one of disciplined execution, manageable leverage and a cautious but intact earnings‑growth path, contingent on a gradual demand recovery and successful price and cost actions.